Bevacizumab Treatment For Type 1 ROP
Bevacizumab Treatment For Type 1 ROP
Active, not recruiting · NCT04634578 · Registry updated 2026-02-11Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bevacizumab Treatment For Type 1 ROP | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Infant, Newborn, Diseases, Infant, Premature, Diseases, eye disorder, retinal disorder, retinopathy of prematurity | Active, not recruiting | Phase 2 | 2026-02-11 | NCT04634578 |
3 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jaeb Center for Health Research | 37 |
| National Eye Institute (NEI) | 122 |
| Pediatric Eye Disease Investigator Group | 5 |
26 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.